What is the global market size of Vacuum-Assisted Breast Biopsy Device Market?

Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 726.81 million in 2021 and is poised to grow from USD 811.85 million in 2022 to USD 2197.62 million by 2030, growing at a CAGR of 11.7% in the forecast period (2023-2030).

Vacuum-Assisted Breast Biopsy Device Market Size, Share, Growth Analysis, By Procedure(Tethered, Untethered), By Product(Vacuum-Assisted Biopsy Systems, Vacuum-Assisted Biopsy Needles), By Type(9-12G, <9G, <12G), By Technique(Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), By End User(Hospitals, Academic, Research Institutes, Diagnostic), By Region - Industry Forecast 2025-2032

Q: Who are the key vendors in the Global Vacuum-Assisted Breast Biopsy Device Market?

The market is dominated by Becton Dickinson and Co (Bd), Devicor Medical Products Inc (Mammotome) and Hologic Inc. Key players in the vacuum-assisted breast biopsy device market are adopting strategies like product launch, merger, and acquisition, and high R&D investments to gain a significant market share. For instance, In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System (Quick-Core Auto) for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system. 'Hologic, Inc.', 'C. R. Bard, Inc.', 'Cook Medical LLC', 'Devicor Medical Products, Inc.', 'Becton, Dickinson and Company', 'Argon Medical Devices, Inc.', 'INRAD, Inc.', 'Medtronic plc', 'STERYLAB S.r.l.', 'Scion Medical Technologies LLC', 'Galini SRL', 'Biopsybell Srl', 'SOMATEX Medical Technologies GmbH', 'Tsunami Medical Srl', 'Micro-Tech (Nanjing) Co., Ltd.', 'Hangzhou AGS MedTech Co., Ltd.', 'Pantheon Medical Technologies S.r.l.', 'Andiamo Corporation', 'OncoCyte Corporation', 'Biodesix, Inc.'

Q: What is the key driver of Global Vacuum-Assisted Breast Biopsy Device Market?

Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods because of their ability to obtain large number of tissues with contiguous specimens, the possibility of acquiring multiple specimens with single insertion of a needle, a more accurate diagnosis with a lower cancer miss rate and lower histological underestimates. Apart from the diagnostic indications, VABB is also a recognized method of therapeutic removal of benign lesions such as fibroadenomas. The use of percutaneous VABB can reduce the need for open surgical biopsy or excision, and minimize costs of the operating theatre or hospital stays associated with surgical excision. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.

Q: What is the key market trend for Global Vacuum-Assisted Breast Biopsy Device Market?

The vacuum-assisted breast biopsy device market is growing as a result of a broad and vigorous research environment, which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer. Governments have also attempted to create a stable and all-encompassing environment for cancer research, which has aided in the development of these diagnostic devices.

Q: Which region accounted for the largest share in Vacuum-Assisted Breast Biopsy Device Market?

The North America region dominates the global vacuum-assisted breast biopsy device market and is projected to maintain a similar trend over the forecast period. North America's vacuum-assisted breast biopsy device market is projected to grow at a CAGR of 4.4% over the forecast period. The US is also the fastest growing country in the region followed by Canada. Each year, over 1 million breast biopsies are performed in the United States, The American Cancer Society, advises women to participate in self-awareness exams held throughout the year, which help individuals detect any changes in their breast that would be further diagnosed by a physician. Moreover, among all the region, The Asia pacific region is fastest growing market. There has been an exponential rise in breast cancer cases in Asian countries over the last few decades. According to a study on breast cancer in Asia, breast cancer mortality increased among Asian women due to a higher prevalence of breast cancer risk factors such as delayed childbirth, and increased obesity.

Report ID: SQSG35A2046 | Region: Global | Published Date: April, 2024
Pages: 286 | Tables: 146 | Figures: 78

Vacuum-Assisted Breast Biopsy Device Market News

In June 2022, Medtronic Plc received FDA 510(k) clearance and CE Mark approval for the integration of advanced INVOS regional oximetry and Micro stream capnography technologies on the CARESCAPE precision monitoring platform. Micro stream capnography (CO2) technology captures evolving respiratory compromise, while INVOSTM regional oximetry (rSO2) technology helps clinicians predict and prevent perioperative complications faster than traditional peripheral measurement.
In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system.

Vacuum-Assisted Breast Biopsy Device Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 726.81 million in 2019 and is poised to grow from USD 811.85 million in 2023 to USD 2197.62 million by 2031, growing at a CAGR of 11.7% in the forecast period (2024-2031).

The market is dominated by Becton Dickinson and Co (Bd), Devicor Medical Products Inc (Mammotome) and Hologic Inc. Key players in the vacuum-assisted breast biopsy device market are adopting strategies like product launch, merger, and acquisition, and high R&D investments to gain a significant market share. For instance, In March 2021, IZI Medical Products, LLC launched The Quick-Core Auto Biopsy System ("Quick-Core Auto") for soft tissue biopsy. Quick-Core Auto is a lightweight, fully automatic biopsy system that offers the precision, dependability, and quality of IZI's Quick-Core semi-automatic biopsy system. 'Hologic, Inc.', 'C. R. Bard, Inc.', 'Cook Medical LLC', 'Devicor Medical Products, Inc.', 'Becton, Dickinson and Company', 'Argon Medical Devices, Inc.', 'INRAD, Inc.', 'Medtronic plc', 'STERYLAB S.r.l.', 'Scion Medical Technologies LLC', 'Galini SRL', 'Biopsybell Srl', 'SOMATEX Medical Technologies GmbH', 'Tsunami Medical Srl', 'Micro-Tech (Nanjing) Co., Ltd.', 'Hangzhou AGS MedTech Co., Ltd.', 'Pantheon Medical Technologies S.r.l.', 'Andiamo Corporation', 'OncoCyte Corporation', 'Biodesix, Inc.'

Vacuum-assisted breast biopsy (VABB) devices are gaining immense popularity over conventional biopsy methods because of their ability to obtain large number of tissues with contiguous specimens, the possibility of acquiring multiple specimens with single insertion of a needle, a more accurate diagnosis with a lower cancer miss rate and lower histological underestimates. Apart from the diagnostic indications, VABB is also a recognized method of therapeutic removal of benign lesions such as fibroadenomas. The use of percutaneous VABB can reduce the need for open surgical biopsy or excision, and minimize costs of the operating theatre or hospital stays associated with surgical excision. Hence, all of these factors are driving the growth of Vacuum-assisted breast biopsy (VABB) devices.

The vacuum-assisted breast biopsy device market is growing as a result of a broad and vigorous research environment, which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer. Governments have also attempted to create a stable and all-encompassing environment for cancer research, which has aided in the development of these diagnostic devices.

The North America region dominates the vacuum-assisted breast biopsy device market and is projected to maintain a similar trend over the forecast period. North America's vacuum-assisted breast biopsy device market is projected to grow at a CAGR of 4.4% over the forecast period. The US is also the fastest growing country in the region followed by Canada. Each year, over 1 million breast biopsies are performed in the United States, The American Cancer Society, advises women to participate in self-awareness exams held throughout the year, which help individuals detect any changes in their breast that would be further diagnosed by a physician. Moreover, among all the region, The Asia pacific region is fastest growing market. There has been an exponential rise in breast cancer cases in Asian countries over the last few decades. According to a study on breast cancer in Asia, breast cancer mortality increased among Asian women due to a higher prevalence of breast cancer risk factors such as delayed childbirth, and increased obesity.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Vacuum-Assisted Breast Biopsy Device Market News

Vacuum-Assisted Breast Biopsy Device Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Vacuum-Assisted Breast Biopsy Device Market?

Who are the key vendors in the Vacuum-Assisted Breast Biopsy Device Market?

What is the key driver of Vacuum-Assisted Breast Biopsy Device Market?

What is the key market trend for Vacuum-Assisted Breast Biopsy Device Market?

Which region accounted for the largest share in Vacuum-Assisted Breast Biopsy Device Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300